Does K280 acetylation causally drive mitochondrial dysfunction or merely correlate as a downstream marker?

molecular-biology open composite 69%
Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
69%
Novelty
72%
Mechanistic
—
Druggability
—
Priority
80%
Importance
88%
Tractability
82%
Market price
50%

Description

The skeptic raised that mitochondrial deficits may precede K280 acetylation in some models, questioning causality. Resolving whether this PTM is a driver versus consequence determines its therapeutic targeting priority and mechanism of action.

Source: Debate session sess_SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd_20260412-091129 (Analysis: SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd)